SHARON BIO-MEDICINE | GANGA PHARMACEUTICALS | SHARON BIO-MEDICINE/ GANGA PHARMACEUTICALS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 0.1 | - | - | View Chart |
P/BV | x | - | 1.1 | - | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
SHARON BIO-MEDICINE GANGA PHARMACEUTICALS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
SHARON BIO-MEDICINE Mar-23 |
GANGA PHARMACEUTICALS Mar-24 |
SHARON BIO-MEDICINE/ GANGA PHARMACEUTICALS |
5-Yr Chart Click to enlarge
|
||
High | Rs | NA | 28 | 0.0% | |
Low | Rs | NA | 8 | 0.0% | |
Sales per share (Unadj.) | Rs | 338.5 | 5.7 | 5,988.2% | |
Earnings per share (Unadj.) | Rs | 33.0 | 0.1 | 33,977.6% | |
Cash flow per share (Unadj.) | Rs | 51.6 | 0.2 | 26,037.2% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | -1,024.9 | 13.3 | -7,713.5% | |
Shares outstanding (eoy) | m | 5.76 | 4.84 | 119.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0 | 3.2 | 0.0% | |
Avg P/E ratio | x | 0 | 187.2 | 0.0% | |
P/CF ratio (eoy) | x | 0 | 90.7 | 0.0% | |
Price / Book Value ratio | x | 0 | 1.4 | -0.0% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 0 | 87 | 0.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 333 | 2 | 18,094.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 1,950 | 27 | 7,126.4% | |
Other income | Rs m | 45 | 2 | 1,864.4% | |
Total revenues | Rs m | 1,994 | 30 | 6,703.7% | |
Gross profit | Rs m | 254 | 1 | 43,712.1% | |
Depreciation | Rs m | 107 | 0 | 21,922.4% | |
Interest | Rs m | 1 | 2 | 33.5% | |
Profit before tax | Rs m | 190 | 1 | 30,166.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 0 | 0.0% | |
Profit after tax | Rs m | 190 | 0 | 40,436.2% | |
Gross profit margin | % | 13.0 | 2.1 | 616.7% | |
Effective tax rate | % | 0 | 26.4 | 0.0% | |
Net profit margin | % | 9.7 | 1.7 | 572.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 1,758 | 58 | 3,057.7% | |
Current liabilities | Rs m | 3,391 | 12 | 28,374.6% | |
Net working cap to sales | % | -83.7 | 166.5 | -50.3% | |
Current ratio | x | 0.5 | 4.8 | 10.8% | |
Inventory Days | Days | 17 | 305 | 5.6% | |
Debtors Days | Days | 488 | 123,161 | 0.4% | |
Net fixed assets | Rs m | 1,372 | 29 | 4,736.8% | |
Share capital | Rs m | 12 | 48 | 23.8% | |
"Free" reserves | Rs m | -5,915 | 16 | -37,084.3% | |
Net worth | Rs m | -5,903 | 64 | -9,179.7% | |
Long term debt | Rs m | 5,580 | 4 | 141,270.1% | |
Total assets | Rs m | 3,130 | 86 | 3,619.8% | |
Interest coverage | x | 307.5 | 1.3 | 22,940.9% | |
Debt to equity ratio | x | -0.9 | 0.1 | -1,538.9% | |
Sales to assets ratio | x | 0.6 | 0.3 | 196.9% | |
Return on assets | % | 6.1 | 2.7 | 227.8% | |
Return on equity | % | -3.2 | 0.7 | -444.1% | |
Return on capital | % | -59.0 | 3.6 | -1,624.0% | |
Exports to sales | % | 73.2 | 0 | - | |
Imports to sales | % | 7.5 | 0 | - | |
Exports (fob) | Rs m | 1,428 | NA | - | |
Imports (cif) | Rs m | 145 | NA | - | |
Fx inflow | Rs m | 1,428 | 0 | - | |
Fx outflow | Rs m | 166 | 0 | - | |
Net fx | Rs m | 1,263 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 411 | -13 | -3,252.7% | |
From Investments | Rs m | -28 | 1 | -2,133.1% | |
From Financial Activity | Rs m | NA | 11 | 2.0% | |
Net Cashflow | Rs m | 384 | 0 | 3,836,400.0% |
Indian Promoters | % | 0.0 | 56.0 | - | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 100.0 | 44.0 | 227.4% | |
Shareholders | 24,837 | 365 | 6,804.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare SHARON BIO-MEDICINE With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | SHARON BIO-MEDICINE | GANGA PHARMACEUTICALS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.53% | 0.00% | 0.90% |
1-Month | -8.29% | 0.00% | 1.21% |
1-Year | -41.85% | 14.85% | 46.20% |
3-Year CAGR | -33.57% | 39.71% | 19.62% |
5-Year CAGR | -40.63% | 20.11% | 26.11% |
* Compound Annual Growth Rate
Here are more details on the SHARON BIO-MEDICINE share price and the GANGA PHARMACEUTICALS share price.
Moving on to shareholding structures...
The promoters of SHARON BIO-MEDICINE hold a 0.0% stake in the company. In case of GANGA PHARMACEUTICALS the stake stands at 56.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SHARON BIO-MEDICINE and the shareholding pattern of GANGA PHARMACEUTICALS.
Finally, a word on dividends...
In the most recent financial year, SHARON BIO-MEDICINE paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
GANGA PHARMACEUTICALS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of SHARON BIO-MEDICINE, and the dividend history of GANGA PHARMACEUTICALS.
For a sector overview, read our pharmaceuticals sector report.
Asian stocks experienced a notable rally alongside US equity futures on Monday, marking a positive turn for the markets. The dollar retreated against other currencies as bond yields declined.